首页 › 基金 › REGENERON PHARMACEUTICALS, INC. › NTLA

REGENERON PHARMACEUTICALS, INC. 对 NTLA 的持仓历史

Intellia Therapeutics, Inc. · 医疗保健

REGENERON PHARMACEUTICALS, INC. 在 Q3 2026 的 13F 申报中披露持有 NTLA(Intellia Therapeutics, Inc.)3,702,995 股,市值约 US$44.7M,约占其申报组合的 24.86%,在其申报持仓中市值排名第 2 位。 REGENERON PHARMACEUTICALS, INC. 最近 8 个申报季度中有 8 个季度披露了 NTLA 持仓,最早可追溯至 Q4 2024。

最新持仓 (Q3 2026)3.70M 股
申报持仓市值$44.66M
组合权重24.86%
首次申报Q4 2024
最近变动持有
更新于2026-11-06

最后更新: 2026-11-06 · 来源: SEC EDGAR Form 13F-HR

REGENERON PHARMACEUTICALS, INC. 对 NTLA 的持仓演变

REGENERON PHARMACEUTICALS, INC. 于 Q4 2024 首次披露 NTLA 持仓:3,702,995 股(约 US$43.2M)。 该持仓在 Q3 2025 达到峰值 3,702,995 股,市值约 US$64.0M。 在 8 次申报中,REGENERON PHARMACEUTICALS, INC. 的持股数量始终未变。 最近一期申报(Q3 2026)显示持股 3,702,995 股、市值约 US$44.7M。

逐季持仓明细

季度股数金额变化
Q4 2024 3.70M $43.18M 新进
Q1 2025 3.70M $26.33M 持有
Q2 2025 3.70M $34.73M 持有
Q3 2025 3.70M $63.95M 持有
Q4 2025 3.70M $33.29M 持有
Q1 2026 3.70M $47.47M 持有
Q2 2026 3.70M $62.65M 持有
Q3 2026 3.70M $44.66M 持有

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 NTLA 与 13F 数据

NTLA(Intellia Therapeutics, Inc.)属于医疗保健行业。我们追踪的基金中还有 38 只申报持有 NTLA,申报仓位最大的包括:方舟投资 (US$285.5M), RA CAPITAL MANAGEMENT, L.P. (US$76.6M), Amova Asset Management Americas, Inc. (US$49.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 NTLA 的基金

查看 NTLA 的全部基金持有人 →

常见问题

How long has REGENERON PHARMACEUTICALS, INC. held NTLA?

REGENERON PHARMACEUTICALS, INC. has disclosed NTLA holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is REGENERON PHARMACEUTICALS, INC.'s current position in NTLA?

As of Q3 2026, REGENERON PHARMACEUTICALS, INC. holds 3.70M shares of NTLA (Intellia Therapeutics, Inc.), valued at $44.66M, representing 24.86% of its reported portfolio and ranking #2.

Has REGENERON PHARMACEUTICALS, INC. been buying or selling NTLA?

In the latest 13F filing (Q3 2026), REGENERON PHARMACEUTICALS, INC. held unchanged its position in NTLA. The position peaked in Q3 2025 at 3.70M shares.

Which other funds hold NTLA?

Other major institutional holders of NTLA include 方舟投资, RA CAPITAL MANAGEMENT, L.P., Amova Asset Management Americas, Inc., among 38 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.